跳至主要内容
临床试验/NL-OMON41489
NL-OMON41489已完成不适用

Assessment of fracture healing by high-resolution peripheral quantitative computed tomography (HR-pQCT) and bone strength analysis in standard care and after immediate administration of calcium supplementation - Fracture healing assessed by HRpQCT in standard care and after calcium

Viecuri Medisch Centrum voor Noord-Limburg0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40

研究概览

简要总结

Trial is onging in other countries

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Postmenopausal women older than 50 years who present themselves in clinic with a distal radius fracture due to a trauma.
  • 2. Patients with a stable distal radius fracture type that is treated by cast immobilization.
  • 3. Patients who understand the conditions of the study and are willing and able to comply with the scheduled biochemical and radiographic evaluations and the prescribed rehabilitation.
  • 4. Patients who signed the Ethics Committee approved specific Informed Consent Form prior to inclusion.

排除标准

  • 1. Patients who underwent surgery of the wrist or radius on a previous occasion on the same side or who need surgery this time.
  • 2. Patients with active or suspected infection such as pneumonia or complicated urinary tract infection in the last 3 months.
  • 3. Patients with malignancy or a pathological fracture in the last 12 months.
  • 4. Patients with a neuromuscular or neurosensory deficit, e.g. Parkinson*s disease, which would limit the ability to assess the performance during the healing period.
  • 5. Patients with known systemic or metabolic disorders leading to progressive bone deterioration, such as: hyperthyroidism, hyperparathyroidism, chronic kidney disease with eGFR<30 ml/min, sarcoidosis, hypercalcemia
  • 6. Patients with an active inflammatory disease during the last year such as rheumatoid arthritis, systemic lupus erythematous, inflammatory bowel disease, e.g. Crohn*s disease and ulcerative colitis.
  • 7. The use of glucocorticoids during the last 12 months.
  • 8. Patients with an allergy to calcium, calcium carbonate, cholecalciferol, aspartame, citric-acid, lactose, dimethicone, methylcellulose, sorbic acid, macrogole, polyvidone, mannitol, orange flavour, natriumsaccharine, starch or sucrose.
  • 9. Patients, who as judged by the principal Investigator, are mentally incompetent or are unlikely to be compliant with the follow-up evaluation schedule.
  • 10. Patients with other severe concurrent joint involvements that can affect their outcome.
  • 11. Patients who are already selected for another trial concerning distal radius fractures.

研究者

发起方
Viecuri Medisch Centrum voor Noord-Limburg

相似试验

Assessment of fracture healing by high-resolution... | 临床试验